StockNews.AI
HAE
StockNews.AI
9 hrs

Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

1. Haemonetics released Q2 FY2026 financial results for investor review. 2. A conference call will be held on November 6, 2025. 3. Earnings materials are available on their Investor Relations website. 4. Haemonetics focuses on healthcare technology and blood component collection.

6m saved
Insight
Article

FAQ

Why Neutral?

While the earnings call indicates transparency, there are no shocking revelations expected.

How important is it?

The earnings report and conference call are relevant for current investor sentiment and expectations.

Why Short Term?

Immediate effects will be observed post-earnings call; long-term impacts depend on results.

Related Companies

BLLCSLPRGO
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Financial release and supplemental presentation accessible online , /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2026, which ended September 27, 2025, are available on the Company's Investor Relations website at www.haemonetics.com.The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 6, 2025. Conference Call and Webcast Information: Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended. Live webcast: Access here or through the Investor Relations section of the Haemonetics website. A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on November 6, 2025 and will remain accessible for one year via the webcast link above. Earnings Materials: Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast: Second Quarter Fiscal 2026 Earnings Release Second Quarter Fiscal 2026 Supplemental Earnings Presentation ABOUT HAEMONETICS Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.  Investor Contacts: Olga Guyette, Vice President-Investor Relations & Treasury      David Trenk, Manager-Investor Relations (781) 356-9763                                              (203) 733-4987 [email protected]                    [email protected]   Media Contact:  Josh Gitelson, Sr. Director-Global Communications  (781) 356-9776  [email protected]  SOURCE Haemonetics Corporation Also from this source

Related News